http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001199999-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbdfa36b677f4ef61245ca725011e221 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2000-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8effb4d8824efb631eb4287852cdc73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc93591b25ac9b105341cb8c8fd66d9c |
| publicationDate | 2001-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001199999-A |
| titleOfInvention | O-linked glycosylated calcitonin derivative |
| abstract | (57) Abstract: Calcitonin or elcatonin in which N-acetyl-D-galactosamine is bonded to an oxygen atom of a side chain hydroxyl group of one residue selected from the group consisting of a serine residue and a threonine residue Derivatives are provided. Effect The calcitonin or elcatonin derivative of the present invention has a blood calcium concentration lowering effect and is expected to be applied to the field of medicine. |
| priorityDate | 2000-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.